质子-捕获相互作用增强了对抗辐射的癌细胞的杀死
Dalong Pang1, Mira Jung1, Alfredo Velena1
1Department of Radiation Medicine, Georgetown University Medical Center, Washington, WA, United States.
Frontiers in oncology
|December 29, 2025
概括
与-11 (BSH11) 结合的质子辐射显示,SQ20-B细胞的癌细胞死亡和长期DNA损伤略有增加. 这种质子-相互作用需要进一步研究潜在的临床应用.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 核医学就是核医学.
背景情况:
- 质子-相互作用正在探索增强癌细胞杀死.
- 之前的理论模型与对质子-子捕获疗法的实验研究结果不一致.
- 这项研究独立调查了质子-相互作用对癌细胞致死性的影响.
研究的目的:
- 评估用-11 (BSH11) 进行质子辐射对癌细胞存活率的影响.
- 评估暴露于质子辐射和BSH11.1的癌细胞中的DNA损伤.
- 为了比较单独的质子辐射和使用BSH11.1的质子辐射的影响.
主要方法:
- 在SQ20-B和MCF-7细胞上进行了克隆基细胞生存测试.
- 线性正方形 (LQ) 和单击多目标 (SHMT) 模型与生存曲线相适应.
- γH2AX焦点定量评估了辐射后的DNA损伤.
主要成果:
- 与对照组相比,用BSH11进行质子辐射降低了SQ-20B细胞存活率.
- 长时间的γH2AX焦点表明,随着BSH11和质子暴露,持续的DNA损伤.
- 没有观察到BSH11和玛辐射或-10 (BSH10) 和质子辐射增强细胞杀死.
结论:
- 在BSH11的存在下进行质子辐射表明,在杀死癌细胞方面有轻微的增强.
- 观察到的细胞杀死增强归因于质子-相互作用.
- 需要进一步的研究来探索在癌症治疗中质子-相互作用的临床相关性.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Nuclear Overhauser Enhancement (NOE)
1.3K
Irradiation of a spin-active nucleus causes an increase or decrease in the signal intensity of neighboring nuclei that are not necessarily chemically bonded or involved in J-coupling. This phenomenon, called the nuclear Overhauser enhancement (NOE), results from through-space interactions between the nuclear spins. The NOE effect decreases with increasing internuclear distance and is generally not observed beyond 4 angstroms. In NOE, dipole-dipole interactions between neighboring spin-active...
1.3K
Drug-Receptor Bonds
4.1K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
4.1K
Biological Effects of Radiation
17.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.5K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


